-

Terumo Neuro (Formerly MicroVention) to Host Grand Opening Ceremony for Newly Expanded Global Headquarters and Innovation Center in Aliso Viejo

ALISO VIEJO, Calif.--(BUSINESS WIRE)--Terumo Neuro:

Who:

- Terumo Neuro CEO, Carsten Schroeder, and Terumo Neuro Executive Team

What:

Terumo Neuro, a global leader in neurovascular medical technology, will celebrate the grand opening of its newly expanded Global Headquarters and Innovation Center. The event will include a ribbon-cutting ceremony, VIP luncheon, and opportunities to tour the facility and interact with Terumo Neuro executives, engineers, and innovators. The expansion follows the recent acquisition of the Pacific Life Building, further demonstrating Terumo Neuro's commitment to growth, innovation, and economic development in California.

When:

Wednesday, October 2, 2024

-12:00 PM – 1:00 PM: VIP Lunch (Invite Only – Media Representatives are Invited, RSVP with Press Officer)

-1:30 PM: Ribbon Cutting Ceremony Commencement

-2:00 PM – 3:00 PM: Light Refreshments with Associates & Photo/Press Opportunities

Where:

Terumo Neuro Global Headquarters and Innovation Center
45 Enterprise, Aliso Viejo, CA 92656

Why:

This grand opening marks a significant milestone in Terumo Neuro's expansion journey, reinforcing the company’s commitment to driving innovation in the medical device industry and contributing to economic growth in Orange County. Attendees will have the opportunity to hear from company executives, witness the ribbon-cutting ceremony, and engage with Terumo Neuro’s team of Aliso Viejo-based Associates.

RSVP:

Media representatives interested in attending are encouraged to RSVP with press contact. For more information, please go to terumoneuro.com.

Contacts

Press Contact:
Christine McCullough
+ 1 714 206 9800 mobile
Christine.mccullough@microvention.com

Terumo Neuro


Release Versions

Contacts

Press Contact:
Christine McCullough
+ 1 714 206 9800 mobile
Christine.mccullough@microvention.com

Social Media Profiles
More News From Terumo Neuro

Terumo Neuro and Tulane University School of Medicine’s Dr. Kendrick Johnson Release Educational Video Highlighting the Importance of Stroke Awareness and Equitable Healthcare in Honor of World Stroke Day 2024

ALISO VIEJO, Calif. & NEW ORLEANS--(BUSINESS WIRE)--In honor of World Stroke Day on October 29, 2024, Terumo Neuro has partnered with Tulane University School of Medicine and Dr. Kendrick Johnson, Assistant Professor of Neurosurgery at Tulane University School of Medicine, to release a compelling educational video focused on raising awareness about stroke education and the critical need for equitable healthcare access. Stroke remains one of the leading causes of death and long-term disability i...

MicroVention Rebrands to Terumo Neuro – Reflects Expanded Focus and Strategic Growth

ALISO VIEJO, Calif.--(BUSINESS WIRE)--MicroVention, Inc., a global leader in neurovascular innovation and a wholly owned subsidiary of Terumo Corporation, today announced its official rebranding to Terumo Neuro, effective immediately. This name change signifies a new chapter in the company’s evolution while maintaining its unwavering commitment to the creation and commercialization of groundbreaking innovations in neurovascular care. Founded in 1997 and acquired by Terumo Corporation in 2006, M...

MicroVention Announces Release of CLinical EValuation of WEB™ 17 Device in Intracranial Aneurysms (CLEVER): One Year Effectiveness Results for Ruptured and Unruptured Aneurysms

COLORADO SPRINGS, Colo. & ALISO VIEJO, Calif.--(BUSINESS WIRE)--MicroVention, Inc., a global neurovascular company and wholly owned subsidiary of Terumo Corporation, today announced the recently published results of the CLinical EValuation of WEB 17 Device in Intracranial Aneurysms (CLEVER): One Year Effectiveness Results for Ruptured and Unruptured Aneurysms. The CLEVER study was a multicenter, prospective study evaluating the WEB 17 system in ruptured and unruptured aneurysms to understand th...
Back to Newsroom